AQP4 and Cognitive impairment: In the present study, we aimed to (i) determine the extent and characteristics of possible cognitive deficits in MOGAD patients compared to HC using an internationally established neuropsychological test battery and (ii) compare the risk of cognitive impairment in MOGAD to that in AQP4+NMOSD, double-seronegative (ds) NMOSD and HC.